Arnold Lippa

Company: RespireRx Pharmaceuticals Inc
Job title: Exec. Chairman, Chief Executive Officer and Chief Scientific Officer
Seminars:
Pharmaceutical Cannabinoids: A Company Update 12:00 pm
Examine re-purposing dronabinol for the treatment of obstructive sleep apnea (OSA) and other indications Explore completion of two successful phase 2 clinical trials in OSA Develop lipid nanoparticle formulation to overcome current dronabinol limitationsRead more
day: Day One Track B - morning